Immo Serbian

459 total citations
33 papers, 394 citations indexed

About

Immo Serbian is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Immo Serbian has authored 33 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Pharmacology and 12 papers in Organic Chemistry. Recurrent topics in Immo Serbian's work include Natural product bioactivities and synthesis (19 papers), Cholinesterase and Neurodegenerative Diseases (10 papers) and Plant biochemistry and biosynthesis (8 papers). Immo Serbian is often cited by papers focused on Natural product bioactivities and synthesis (19 papers), Cholinesterase and Neurodegenerative Diseases (10 papers) and Plant biochemistry and biosynthesis (8 papers). Immo Serbian collaborates with scholars based in Germany, Oman and Russia. Immo Serbian's co-authors include René Csük, Sophie Hoenke, Anne Loesche, Hans‐Peter Deigner, Sven Sommerwerk, Ahmed Al‐Harrasi, Lucie Heller, Bianka Siewert, E. F. Khusnutdinova and Wolfgang Brandt and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Tetrahedron.

In The Last Decade

Immo Serbian

33 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Immo Serbian Germany 14 287 90 77 40 38 33 394
Sophie Hoenke Germany 14 338 1.2× 113 1.3× 61 0.8× 26 0.7× 31 0.8× 51 488
Cynthia Jeffries United States 10 193 0.7× 105 1.2× 75 1.0× 26 0.7× 47 1.2× 17 380
Jana Wiemann Germany 13 263 0.9× 103 1.1× 81 1.1× 45 1.1× 41 1.1× 18 384
Junkai Liu China 7 166 0.6× 99 1.1× 51 0.7× 35 0.9× 49 1.3× 8 317
Anne Loesche Germany 13 204 0.7× 110 1.2× 121 1.6× 41 1.0× 38 1.0× 23 361
Chanokbhorn Phaosiri Thailand 10 207 0.7× 72 0.8× 67 0.9× 51 1.3× 41 1.1× 25 328
Chuansheng Yao China 9 151 0.5× 65 0.7× 72 0.9× 34 0.8× 43 1.1× 14 359
Fang‐Dao Wang China 9 249 0.9× 143 1.6× 56 0.7× 63 1.6× 65 1.7× 16 429
Habsah Mohamad Malaysia 11 144 0.5× 107 1.2× 70 0.9× 54 1.4× 17 0.4× 22 357
Roberta Cotugno Italy 12 279 1.0× 41 0.5× 56 0.7× 103 2.6× 39 1.0× 23 422

Countries citing papers authored by Immo Serbian

Since Specialization
Citations

This map shows the geographic impact of Immo Serbian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Immo Serbian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Immo Serbian more than expected).

Fields of papers citing papers by Immo Serbian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Immo Serbian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Immo Serbian. The network helps show where Immo Serbian may publish in the future.

Co-authorship network of co-authors of Immo Serbian

This figure shows the co-authorship network connecting the top 25 collaborators of Immo Serbian. A scholar is included among the top collaborators of Immo Serbian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Immo Serbian. Immo Serbian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serbian, Immo, et al.. (2024). An asiatic acid derived trisulfamate acts as a nanomolar inhibitor of human carbonic anhydrase VA. Steroids. 205. 109381–109381. 4 indexed citations
2.
Hoenke, Sophie, et al.. (2022). An improved partial synthesis of corosolic acid and its conversion to highly cytotoxic mitocans. SHILAP Revista de lepidopterología. 6. 100073–100073. 9 indexed citations
3.
Hoenke, Sophie, et al.. (2022). Synthesis and cytotoxicity of apoptosis-inducing N-heterocyclic triterpene amides. SHILAP Revista de lepidopterología. 6. 100085–100085. 5 indexed citations
4.
Hoenke, Sophie, et al.. (2022). Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents. International Journal of Molecular Sciences. 23(8). 4362–4362. 14 indexed citations
5.
Hoenke, Sophie, et al.. (2022). Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs. Molecules. 27(7). 2220–2220. 15 indexed citations
6.
Güttler, Antje, Immo Serbian, Jacqueline Keßler, et al.. (2021). MSBA-S – A pentacyclic sulfamate as a new option for radiotherapy of human breast cancer cells. European Journal of Medicinal Chemistry. 224. 113721–113721. 11 indexed citations
7.
Khusnutdinova, E. F., А. Н. Лобов, И. П. Байкова, et al.. (2021). Synthesis of messagenin and platanic acid chalcone derivatives and their biological potential. Natural Product Research. 36(20). 5189–5198. 16 indexed citations
8.
Serbian, Immo, Erik Prell, Claudia Fischer, Hans‐Peter Deigner, & René Csük. (2021). n-Propyl 6-amino-2,6-dideoxy-2,2-difluoro-β-d-glucopyranoside is a good inhibitor for the β-galactosidase from E. coli. Medicinal Chemistry Research. 30(5). 1099–1107. 2 indexed citations
9.
Serbian, Immo, et al.. (2020). Ester and amide derivatives of rhodamine B exert cytotoxic effects on different human tumor cell lines. Medicinal Chemistry Research. 29(9). 1655–1661. 17 indexed citations
10.
Hoenke, Sophie, Immo Serbian, Hans‐Peter Deigner, & René Csük. (2020). Mitocanic Di- and Triterpenoid Rhodamine B Conjugates. Molecules. 25(22). 5443–5443. 42 indexed citations
11.
Serbian, Immo, Erik Prell, Ahmed Al‐Harrasi, & René Csük. (2020). Stereoselective synthesis of alkyl pyranosides on a laboratory scale. Mediterranean Journal of Chemistry. 10(3). 269–276. 1 indexed citations
12.
Hoenke, Sophie, et al.. (2020). Cytotoxic triterpenoid–safirinium conjugates target the endoplasmic reticulum. European Journal of Medicinal Chemistry. 209. 112920–112920. 18 indexed citations
13.
Loesche, Anne, et al.. (2019). Caffeic acid phenethyl ester (CAPE)-derivatives act as selective inhibitors of acetylcholinesterase. European Journal of Medicinal Chemistry. 177. 259–268. 15 indexed citations
14.
Hoenke, Sophie, et al.. (2019). Synthesis of amide-spacered dimers of ursolic and oleanolic acid. Mediterranean Journal of Chemistry. 9(1). 24–36. 1 indexed citations
15.
Loesche, Anne, et al.. (2019). The cytotoxicity of oleanane derived aminocarboxamides depends on their aminoalkyl substituents. Steroids. 149. 108422–108422. 21 indexed citations
16.
Loesche, Anne, et al.. (2019). Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase. Molecules. 24(5). 948–948. 20 indexed citations
17.
18.
Serbian, Immo, Bianka Siewert, Ahmed Al‐Harrasi, & René Csük. (2019). 2-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells. European Journal of Medicinal Chemistry. 180. 457–464. 10 indexed citations
19.
Serbian, Immo, et al.. (2018). Hydroxylated boswellic and glycyrrhetinic acid derivatives: synthesis and cytotoxicity. Mediterranean Journal of Chemistry. 7(4). 286–293. 7 indexed citations
20.
Serbian, Immo & René Csük. (2018). An Improved Scalable Synthesis of α- and β-Amyrin. Molecules. 23(7). 1552–1552. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026